Hamburger

Call: 1-202-476-5000

 
Find a Doctor
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
     
 

Catherine Mary Bollard, MD, MBChB

Departments
Blood and Marrow Transplantation


Children’s Research Institute (CRI)
Center for Cancer and Immunology Research


National Provider Identifier1639259062
E-Mail

Service LocationsChildren's National Medical Center - Sheikh Zayed Campus for Advanced Children's Medicine
111 Michigan Avenue, NW
Washington, DC 20010
Map | Driving Directions

Phone: 202-476-5000
Biography

Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, is a senior scientist in the Center for Cancer and Immunology Research at the Children’s Research Institute, a member of the Division of the Blood and Marrow Transplantation, and the Principal Investigator and Co-Director of the Immunology Initiative of the Sheikh Zayed Institute for Pediatric Surgical Innovation. In this role, she will lead clinical and research efforts to fight cancer and other inflammatory diseases by strengthening a child’s immune system.

A distinguished hematologist and immunotherapist, Dr. Bollard’s research interests focus on three different areas including developing cell and gene therapies for patients with cancer and underlying immune deficiencies. She is also interested in stem cell and cord blood transplantation, and improving outcomes by decreasing infectious complications and preventing relapse. She also has a specific interest in cell therapies for EBV-associated lymphomas and as head of the NHL committee of the Children’s Oncology Group is moving cell therapies to the cooperative group setting.
Education
TypeSchoolLocationDegreeField of StudyYears
Medical School University of Otago Dunedin, New ZealandDoctor of Medicine 1986 -1991
Medical School University of Otago Dunedin, New ZealandDoctor of Medicine 2000 -2005
National & International Recognitions
AwardInstitutionEventYear
Basic Science AwardEuropean Group for Blood and Marrow Transplantation (EBMT)2011
Invited Professor: Janet J. Fischer Memorial LectureshipUniversity of North Carolina2011
Best Abstract AwardAmerican Society of Gene Therapy (ASGT)2009

Affiliations and Memberships
TitleInstitutionCommittee / SectionYears
ChairChildren’s Oncology GroupNHL committee2012 - 2017
Co-ChairISCT Annual Meeting Scientific Program Committee2012 - 2013
ChairAmerican Society of Blood and Marrow Transplantation (ASBMT)Annual Meeting Scientific Program Committee2012 - 2013
Core Center PINHLBI/NCI Blood and Marrow TransplantClinical Trials Network Steering Committee (CTN)2011
MemberNCI Hodgkin's Lymphoma Working Group2011
ChairISCTPublications Committee2010
MemberCIBMTRClinical Trials Advisory Committee2012
Research
TitleStudy NameInstitutionYears
Principal Investigator
Publications
Journal Article, G Weber, U Gerdemann, I Caruana, B Savoldo, K Rabin, EJ Shpall, NF Hensel, JJ Melenhorst, AM. Leen, AJ Barrett, CM. Bollard (2013), Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant, Leukemia , 27, 7, 1538-1547.

Journal Article, Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, Shpall EJ, Krance RA, Kamble RT, Carrum G, Hosing CM, Gee AP, Mei Z, Grilley BJ, Heslop HE, Rooney CM, B (2013), Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study, Blood, 122, 17, 2965-2973.

Journal Article, Cruz CR, Gerdemann U, Leen AM, Shafer JA, Ku S, Tzou B, Horton TM, Copeland A, Younes A, Rooney CM, Heslop HE, Bollard CM (2011), Improving T cell therapy for relapsed EBV negative Hodgkins Lymphoma by targeting upregulated MAGE-A4, Clin Cancer Res.

Journal Article, Safdar A, Decker WK, Li S, Xing D, Robinson SN, Yang H, Steiner D, Rodriguez G, Shpall EJ, Bollard C (2009), De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination, Vaccine, 27, 10, 1479-1484.

Journal Article, Hanley P, Cruz CR, Savoldo B, Leen AM, Decker WK, Molldrem JJ, Liu H, Gee A, Rooney C, Heslop HE, Dotti G, Brenner MK, Shpall EJ, Bollard CM (2009), Functionally Active Virus-Specific T-Cells that target CMV, Adenovirus and EBV can be Expanded From Naïve T Cell Populations in Cord Blood and will Target a Broad Range of Viral Epitopes, Blood, 114, 9, 1958-1967.

Journal Article, Leen AM, Christin A, Myers GD, Liu H, Cruz CR, Hanley PJ, Kennedy-Nasser AA, Leung KS, Gee AP, Krance RA, Brenner MK, Heslop HE, Rooney CM, Bollard CM (2009), Cytotoxic T Lymphocyte Therapy With Donor T Cells Prevents And Treats Adenovirus And Epstein-Barr Virus Infections After Haploidentical And Matched Unrelated Stem Cell Transplant, Blood, 114, 19, 4283-4292.

Journal Article, AM. Leen, A Christin, M Khalil, H Weiss, AP. Gee, MK. Brenner, HE. Heslop, CM. Rooney, and CM. Bollard (2008), Adenovirus hexon-specific CD4 and CD8 T cell epitopes for vaccine and immunotherapy, Virol, 82, 1, 546-554.

Journal Article, CM Bollard, S Gottschalk, AM Leen, H Weiss,KC Straathof, G Carrum, M Khalil, M Wu, MH Huls, CC Chang, MV Gresik, AP Gee, MK Brenner, CM Rooney, HE Heslop (2007), Complete Responses of Relapsed Lymphoma Following Genetic Modification of Tumor-Antigen Presenting Cells and T-lymphocyte transfer, Blood, 110, 8, 2838-2845.

Journal Article, AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, RA Krance, JJ Molldrem, AP Gee, MK Brenner, HE Heslop, CM Rooney, CM Bollard (2006), Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised patients, Nature Medicine, 12, 10, 1160-1166.

Journal Article, Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Brenner MK, Rooney CM, Heslop HE (2004), The use of EBV-specific Cytotoxic T cells for EBV+ve Hodgkin Disease, Exp Medicine, 200, 12, 1623-1633.


For a more comprehensive list of publications for Catherine Bollard, MD, MBChB view the National Library of Medicine’s PubMed online database
 


   
Feedback Form